Investing Ideas
/
German Pharmaceuticals & Biotech High Insider Buying

German Pharmaceuticals & Biotech High Insider Buying

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

1 companies

Biomark Diagnostics

Market Cap: €39.1m

Develops early-stage cancer diagnostic technology platform to detect and treat cancer.

20B

€0.36

2.2%

182.2%